These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11489795)

  • 61. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 62. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
    Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
    Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
    Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
    Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
    Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Analyses of p53 mutations in breast cancers with a combined use of yeast functional assay and immunohistochemical staining].
    Takahashi M
    Hokkaido Igaku Zasshi; 1998 May; 73(3):275-86. PubMed ID: 9719952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
    Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G
    Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
    Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
    Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
    McKenzie KE; Siva A; Maier S; Runnebaum IB; Seshadri R; Sukumar S
    Clin Cancer Res; 1997 Sep; 3(9):1669-73. PubMed ID: 9815858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients.
    Paradiso A; Tommasi S; Barletta A; Leone B; Lacava J; Vellejo C; Labriola A; Marzullo F; Altieri R; Schittulli F; De Lena M
    Anticancer Res; 1999; 19(5C):4523-8. PubMed ID: 10650804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.
    Trivers GE; De Benedetti VM; Cawley HL; Caron G; Harrington AM; Bennett WP; Jett JR; Colby TV; Tazelaar H; Pairolero P; Miller RD; Harris CC
    Clin Cancer Res; 1996 Oct; 2(10):1767-75. PubMed ID: 9816128
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
    Thorlacius S; Börresen AL; Eyfjörd JE
    Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.
    Coutant C; Rouzier R; Qi Y; Lehmann-Che J; Bianchini G; Iwamoto T; Hortobagyi GN; Symmans WF; Uzan S; Andre F; de Thé H; Pusztai L
    Clin Cancer Res; 2011 Apr; 17(8):2591-601. PubMed ID: 21248301
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection.
    Liang JT; Cheng YM; Chang KJ; Chien CT; Hsu HC
    Hepatogastroenterology; 1999; 46(26):830-7. PubMed ID: 10370622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer.
    Gallo O; Chiarelli I; Bianchi S; Calzolari A; Simonetti L; Porfirio B
    Clin Cancer Res; 1996 Sep; 2(9):1577-82. PubMed ID: 9816336
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
    Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.
    Saunders ME; MacKenzie R; Shipman R; Fransen E; Gilbert R; Jordan RC
    Clin Cancer Res; 1999 Sep; 5(9):2455-63. PubMed ID: 10499619
    [TBL] [Abstract][Full Text] [Related]  

  • 79. p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis.
    Saitoh S; Cunningham J; De Vries EM; McGovern RM; Schroeder JJ; Hartmann A; Blaszyk H; Wold LE; Schaid D; Sommer SS
    Oncogene; 1994 Oct; 9(10):2869-75. PubMed ID: 8084591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.
    Ichikawa A; Kinoshita T; Watanabe T; Kato H; Nagai H; Tsushita K; Saito H; Hotta T
    N Engl J Med; 1997 Aug; 337(8):529-34. PubMed ID: 9262496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.